Literature DB >> 17098397

Association of protein kinase C-delta with the B cell antigen receptor complex.

Catrin Pracht1, Susana Minguet, Michael Leitges, Michael Reth, Michael Huber.   

Abstract

Protein kinase C (PKC)-delta is a diacylglycerol-dependent, calcium-independent novel PKC isoform and has been demonstrated to exert negative regulatory functions in B lymphocytes as well as in mast cells. Whereas in mast cells PKC-delta functionally interacts with the high-affinity receptor for IgE, FcepsilonR1, no such association has been described for the B cell antigen receptor (BCR). In this report, for the first time, we demonstrate the interaction of PKC-delta with different classes of BCR by means of affinity purification and native protein complex analysis. Using a C-terminally truncated Ig-alpha as well as non-phosphorylated and phosphorylated peptides representing C-terminal regions of Ig-alpha, the dependence of this BCR/PKC-delta interaction on tyrosine-phosphorylated Ig-alpha is shown. Finally, splenocytes from PKC-delta-deficient mice are found to exert reduced phosphorylation of PKD (a.k.a. PKC-mu) in response to BCR engagement, suggesting the early, membrane-proximal activation of an attenuating kinase complex including PKC-delta and PKD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17098397     DOI: 10.1016/j.cellsig.2006.07.023

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  7 in total

Review 1.  Autoimmunity checkpoints as therapeutic targets in B cell malignancies.

Authors:  Markus Müschen
Journal:  Nat Rev Cancer       Date:  2018-01-05       Impact factor: 60.716

2.  A novel Lyn-protein kinase Cδ/ε-protein kinase D axis is activated in B cells by signalosome-independent alternate pathway BCR signaling.

Authors:  Benchang Guo; Thomas L Rothstein
Journal:  Eur J Immunol       Date:  2013-04-12       Impact factor: 5.532

3.  Unique functions for protein kinase D1 and protein kinase D2 in mammalian cells.

Authors:  Sharon A Matthews; Maria N Navarro; Linda V Sinclair; Elizabeth Emslie; Carmen Feijoo-Carnero; Doreen A Cantrell
Journal:  Biochem J       Date:  2010-11-15       Impact factor: 3.857

4.  New mutations in chronic lymphocytic leukemia identified by target enrichment and deep sequencing.

Authors:  Elena Doménech; Gonzalo Gómez-López; Daniel Gzlez-Peña; Mar López; Beatriz Herreros; Juliane Menezes; Natalia Gómez-Lozano; Angel Carro; Osvaldo Graña; David G Pisano; Orlando Domínguez; José A García-Marco; Miguel A Piris; Margarita Sánchez-Beato
Journal:  PLoS One       Date:  2012-06-01       Impact factor: 3.240

5.  Phosphoinositide-dependent protein kinase-1 (PDK1)-independent activation of the protein kinase C substrate, protein kinase D.

Authors:  C David Wood; April P Kelly; Sharon A Matthews; Doreen A Cantrell
Journal:  FEBS Lett       Date:  2007-07-02       Impact factor: 4.124

Review 6.  The dual role of HLA-G in cancer.

Authors:  Nathalie Rouas-Freiss; Philippe Moreau; Joel LeMaoult; Edgardo D Carosella
Journal:  J Immunol Res       Date:  2014-03-31       Impact factor: 4.818

7.  Protein kinase D-dependent CXCR4 down-regulation upon BCR triggering is linked to lymphadenopathy in chronic lymphocytic leukaemia.

Authors:  Stéphane Saint-Georges; Maude Quettier; Marouane Bouyaba; Stéphanie Le Coquil; Vanessa Laurienté; Lionel Guittat; Vincent Lévy; Florence Ajchenbaum-Cymbalista; Nadine Varin-Blank; Christine Le Roy; Dominique Ledoux
Journal:  Oncotarget       Date:  2016-07-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.